Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vania Altrinetti

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Chemical Immunology and Allergy|September 2, 2003
Allergen biodistribution in humansMarcello Bagnasco, Silvia Morbelli, Vania Altrinetti, et al.
Current Oncology Reports|November 19, 2011
Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancerAlessandra Gennari, Arnoldo Piccardo, Vania Altrinetti, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 10, 2021
Radioiodine therapy of Graves' diseaseArnoldo Piccardo, Martina Ugolini, Vania Altrinetti, et al.
International Archives of Allergy and Immunology|October 6, 2005
Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteersMarcello Bagnasco, Vania Altrinetti, Giampaola Pesce, et al.
Clinical Nuclear Medicine|December 18, 2012
Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survivalArnoldo Piccardo, Federico Arecco, Matteo Puntoni, et al.
Clinical Nuclear Medicine|December 21, 2002
The incidental discovery of follicular thyroid cancer with in-111 pentetreotide scintigraphy in a patient with carcinoid tumor of the lungGiuseppe Villa, Giovanni B Ratto, Marco Carletto, et al.
Clinical Nuclear Medicine|March 7, 2012
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MREgesta Lopci, Arnoldo Piccardo, Cristina Nanni, et al.
European Journal of Radiology|January 10, 2012
Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT. Preliminary experienceArnoldo Piccardo, Vania Altrinetti, Lorenzo Bacigalupo, et al.
Pediatric Blood & Cancer|October 25, 2020
<sup>131</sup> I-Meta-iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high-risk neuroblastomaStefano Giardino, Arnoldo Piccardo, Massimo Conte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2018
Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?Arnoldo Piccardo, Matteo Puntoni, Giulia Ferrarazzo, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Chemical Immunology and Allergy|September 2, 2003
Allergen biodistribution in humansMarcello Bagnasco, Silvia Morbelli, Vania Altrinetti, et al.
Current Oncology Reports|November 19, 2011
Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancerAlessandra Gennari, Arnoldo Piccardo, Vania Altrinetti, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 10, 2021
Radioiodine therapy of Graves' diseaseArnoldo Piccardo, Martina Ugolini, Vania Altrinetti, et al.
International Archives of Allergy and Immunology|October 6, 2005
Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteersMarcello Bagnasco, Vania Altrinetti, Giampaola Pesce, et al.
Clinical Nuclear Medicine|December 18, 2012
Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survivalArnoldo Piccardo, Federico Arecco, Matteo Puntoni, et al.
Clinical Nuclear Medicine|December 21, 2002
The incidental discovery of follicular thyroid cancer with in-111 pentetreotide scintigraphy in a patient with carcinoid tumor of the lungGiuseppe Villa, Giovanni B Ratto, Marco Carletto, et al.
Clinical Nuclear Medicine|March 7, 2012
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MREgesta Lopci, Arnoldo Piccardo, Cristina Nanni, et al.
European Journal of Radiology|January 10, 2012
Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT. Preliminary experienceArnoldo Piccardo, Vania Altrinetti, Lorenzo Bacigalupo, et al.
Pediatric Blood & Cancer|October 25, 2020
<sup>131</sup> I-Meta-iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high-risk neuroblastomaStefano Giardino, Arnoldo Piccardo, Massimo Conte, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 21, 2018
Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?Arnoldo Piccardo, Matteo Puntoni, Giulia Ferrarazzo, et al.
Pageof 2